Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dis Esophagus ; 30(2): 1-8, 2017 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-26725535

RESUMO

The consequences of using aspirin (ASA) for the pathogenesis of Chagas disease are unclear. This study evaluated the effects of treatment of Chagas disease with ASA on the esophageal nitrergic myenteric neuron population and esophageal wall in mice. We observed that treatment of chagasic infection with ASA protects the esophageal myenteric neurons from the atrophy caused by the Trypanosoma cruzi infection. The mice were infected with 1300 trypomastigotes of Y strain T. cruzi intraperitoneally. Part of infected mice was treated with ASA from fifth to twelfth day after inoculation. Our data support the hypothesis that eicosanoids given during the acute phase of the chagasic infection may act as immunomodulators aiding the transition to and maintenance of the chronic phase of the disease. Besides, ASA treatment did not provoke alterations in the esophageal wall and the myenteric neurons in infected mice.


Assuntos
Aspirina/farmacologia , Doença de Chagas/tratamento farmacológico , Inibidores de Ciclo-Oxigenase/farmacologia , Esôfago/inervação , Plexo Mientérico/efeitos dos fármacos , Neurônios Nitrérgicos/efeitos dos fármacos , Animais , Atrofia/prevenção & controle , Doença de Chagas/parasitologia , Doença Crônica , Modelos Animais de Doenças , Masculino , Camundongos , Plexo Mientérico/patologia , Neurônios Nitrérgicos/patologia , Resultado do Tratamento , Trypanosoma cruzi/efeitos dos fármacos
2.
Cancer Immunol Immunother ; 61(4): 481-8, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21959683

RESUMO

Antineoplastic chemotherapy still consists in the major first-line therapeutics against cancer. Several reports have described the immunomodulatory effects of these drugs based on in vitro treatment, but no previous data are known about these effects in patients and its association with immunological-mediated toxicity. In this study, we first characterize the immunological profile of advanced breast cancer patients treated with doxorubicin and paclitaxel protocols, immediately after chemotherapy infusion. Our findings included an immediate plasmatic reduction in IL-1, IL-10, and TNF-α levels in doxorubicin-treated patients, as well as high levels of IL-10 in paclitaxel patients. Further, it was demonstrated that both drugs led to leukocytes oxidative burst impairment. In vitro analysis was performed exposing healthy blood to both chemotherapics in the same concentration and time of exposition of patients, resulting in low IL-10 and high IL-1ß in doxorubicin exposition, as low TNF-α and high IL-1 in paclitaxel treatment. Nitric oxide levels were not altered in both in vivo and in vitro treatments. In conclusion, our data revealed for the first time that the immediate effects of chemotherapy could be mediated by cytokines signaling in patients and that the results observed in patients could be a resultant of host immune cells activation.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Carcinoma/tratamento farmacológico , Doxorrubicina/administração & dosagem , Paclitaxel/administração & dosagem , Adulto , Idoso , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/imunologia , Neoplasias da Mama/patologia , Carcinoma/diagnóstico , Carcinoma/imunologia , Carcinoma/patologia , Citocinas/sangue , Doxorrubicina/efeitos adversos , Feminino , Humanos , Imunomodulação , Pessoa de Meia-Idade , Óxido Nítrico/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Paclitaxel/efeitos adversos
3.
Breast Cancer Res Treat ; 133(3): 881-8, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22048816

RESUMO

Breast cancer is the malignant neoplasia with the highest incidence in women worldwide. Chronic oxidative stress and inflammation have been indicated as major mediators during carcinogenesis and cancer progression. Human studies have not considered the complexity of tumor biology during the stages of cancer advance, limiting their clinical application. The purpose of this study was to characterize systemic oxidative stress and immune response parameters in early (ED; TNM I and II) and advanced disease (AD; TNM III and IV) of patients diagnosed with infiltrative ductal carcinoma breast cancer. Oxidative stress parameters were evaluated by plasmatic lipoperoxidation, carbonyl content, thiobarbituric reactive substances (TBARS), nitric oxide levels (NO), total radical antioxidant parameter (TRAP), superoxide dismutase, and catalase activities and GSH levels. Immune evaluation was determined by TNF-α, IL-1ß, IL-12, and IL-10 levels and leukocytes oxidative burst evaluation by chemiluminescence. Tissue damage analysis included heart (total CK and CKMB), liver (AST, ALT, GGT), and renal (creatinine, urea, and uric acid) plasmatic markers. C-reactive protein (CRP) and iron metabolism were also evaluated. Analysis of the results verified different oxidative stress statuses occur at distinct cancer stages. ED was characterized by reduction in catalase, 8-isoprostanes, and GSH levels, with enhanced lipid peroxidation and TBARS levels. AD exhibited more pronounced oxidative status, with reduction in catalase activity and TRAP, intense lipid peroxidation and high levels of NO, TBARs, and carbonyl content. ED patients presented a Th2 immune pattern, while AD exhibited Th1 status. CRP levels and ferritin were increased in both stages of disease. Leukocytes burst impairment was observed in both the groups. Plasma iron levels were significantly elevated in AD. The data obtained indicated that oxidative stress enhancement and immune response impairment may be necessary to ensure cancer progression to advanced stages and may result from both host and tumor inflammatory mediators.


Assuntos
Neoplasias da Mama/imunologia , Neoplasias da Mama/metabolismo , Adulto , Idoso , Neoplasias da Mama/patologia , Citocinas/sangue , Feminino , Humanos , Mediadores da Inflamação/sangue , Peroxidação de Lipídeos , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Óxido Nítrico/sangue , Oxirredução , Linfócitos T Auxiliares-Indutores/imunologia , Linfócitos T Auxiliares-Indutores/metabolismo , Adulto Jovem
4.
Neurogastroenterol Motil ; 29(10): 1-13, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28524628

RESUMO

BACKGROUND: Experimental and clinical studies have shown that myenteric neuron cell death during infection with Trypanosoma cruzi mainly occurs in the esophagus and colon, resulting in megaesophagus and megacolon, respectively. Evidence suggests that the cyclooxygenase enzyme (COX) is involved in the T. cruzi invasion process. The use of low-dose aspirin (ASA), a COX-1/COX-2 inhibitor, has been shown to reduce infection with T. cruzi. Therefore, in this study, we evaluated the effects of treatment with low-dose ASA on myenteric colonic neurons during murine infection with T. cruzi. METHODS: Swiss mice were assigned into groups treated with either phosphate-buffered saline or low doses of ASA during the acute phase (20 mg/kg ASA) and chronic phase (50 mg/kg ASA) of infection with the Y strain of T. cruzi. Seventy-five days after infection, colon samples were collected to quantify inflammatory foci in histological sections and also general (myosin-V+ ), nitrergic, and VIPergic myenteric neurons in whole mounts. Gastrointestinal transit time was also measured. KEY RESULTS: Aspirin treatment during the acute phase of infection reduced parasitemia (P<.05). Aspirin treatment during the acute or chronic phase of the infection reduced the intensity of inflammatory foci in the colon, protected myenteric neurons from cell death and plastic changes, and recovered the gastrointestinal transit of mice infected with T. cruzi (P<.05). CONCLUSION & INFERENCES: Early and delayed treatment with low-dose ASA can reduce the morphofunctional damage of colonic myenteric neurons caused by murine T. cruzi infection.


Assuntos
Aspirina/farmacologia , Doença de Chagas/patologia , Inibidores de Ciclo-Oxigenase/farmacologia , Plexo Mientérico/efeitos dos fármacos , Animais , Modelos Animais de Doenças , Masculino , Camundongos , Plexo Mientérico/patologia , Neurônios/efeitos dos fármacos , Neurônios/patologia , Fármacos Neuroprotetores/farmacologia , Trypanosoma cruzi
5.
Immunol Lett ; 96(2): 283-90, 2005 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-15585334

RESUMO

We have previously demonstrated that Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi, the protozoa that causes Chagas' disease. These antigens are recognized by human sera and induce protective immunity in Balb/c mice. In the present study, inducible nitric oxide synthase (iNOS) knockout (KO) mice and C57BL/6 mice treated with the nitric oxide inhibitor, aminoguanidine (AG, 50 mg kg(-1)) infected with T. cruzi, were used to demonstrate the role of nitric oxide (NO) to host protection against T. cruzi infection achieved by oral immunization with live P. serpens. A reduction in parasitaemia and an increase in survival were observed in C57BL/6 infected mice and previously immunized with P. serpens, when compared to non-immunized mice. iNOS (KO) mice immunized and C57BL/6 immunized and treated with AG presented parasitaemia and mortality rates comparable to those of infected and non-immunized mice. By itself, immunization with P. serpens did not induce inflammation in the myocardium, but C57BL/6 mice so immunized showed fewer amastigotes nests in the heart following an acute T. cruzi infection than those in non-immunized mice. These results suggest that protective immunity against T. cruzi infection induced by immunization with P. serpens is dependent upon enhanced NO production during the acute phase of T. cruzi infection.


Assuntos
Doença de Chagas/prevenção & controle , Imunoterapia Ativa , Óxido Nítrico Sintase/fisiologia , Óxido Nítrico/fisiologia , Trypanosoma cruzi/imunologia , Trypanosomatina/imunologia , Administração Oral , Animais , Sangue/parasitologia , Doença de Chagas/genética , Coração/parasitologia , Camundongos , Camundongos Knockout , Miocárdio/patologia , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II
6.
Immunol Lett ; 63(1): 1-8, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9719432

RESUMO

The mechanisms that control TNF-alpha production by macrophages during Trypanosoma cruzi infection are still unknown. Destruction of intracellular forms by cytokine activated macrophages is considered to be a major mechanism of parasite elimination. Although in vitro TNF-alpha contributes to enhanced parasite destruction by macrophages, previous work in vivo has shown that as the parasite burden increases, serum TNF-alpha levels decline. In this report we show that TNF-alpha production by peritoneal adherent cells is elevated at the initial phase of T. cruzi infection. As infection progresses TNF-alpha production decreases. The observed reduction is partly due to inhibition, largely exerted by endogenous PG and secondarily by NO. Inhibition of their synthesis partially restored the ability to produce high levels of TNF-alpha to macrophages upon stimulation by LPS. Neither endogenous IL-10 nor TGF-beta seem to be involved in the negative regulation of TNF-alpha production.


Assuntos
Doença de Chagas/imunologia , Doença de Chagas/metabolismo , Óxido Nítrico/fisiologia , Prostaglandinas/fisiologia , Fator de Necrose Tumoral alfa/biossíntese , Animais , Células Cultivadas , Macrófagos Peritoneais/citologia , Macrófagos Peritoneais/metabolismo , Macrófagos Peritoneais/parasitologia , Camundongos , Camundongos Endogâmicos C57BL , Trypanosoma cruzi/metabolismo
7.
FEMS Immunol Med Microbiol ; 39(3): 257-64, 2003 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-14642311

RESUMO

The immune cross-reactivity between Trypanosoma cruzi, the protozoan that causes Chagas' disease, and Phytomonas serpens, a trypanosomatid that infects tomatoes, was studied. Sera from patients with Chagas' disease presented a strong reactivity with P. serpens antigens by conventional serological assays such as indirect immunofluorescence (IIF) and direct agglutination test (DAT), confirmed after cross-absorption experiments. The results show that this protozoan is highly immunogenic and that rabbit and mouse hyperimmune serum raised against T. cruzi or P. serpens was able to recognize both T. cruzi and P. serpens antigens in immunofluorescence and agglutination assays. The antigenic cross-reactivity between T. cruzi and P. serpens was also demonstrated in vivo. BALB/c mice immunized by the intraperitoneal or oral route with P. serpens and later challenged with a lethal inoculum of T. cruzi blood forms showed a significant decrease in parasitemia and increase in survival compared to controls. A practical implication of these findings is that the ingestion by humans or animals of living plant trypanosomatids present in naturally infected edible fruits could potentially prime the immune response to T. cruzi antigens and interfere with the development of T. cruzi infection.


Assuntos
Antígenos de Protozoários/imunologia , Doença de Chagas/imunologia , Trypanosoma cruzi/imunologia , Trypanosomatina/imunologia , Testes de Aglutinação , Animais , Doença de Chagas/parasitologia , Doença de Chagas/prevenção & controle , Reações Cruzadas/imunologia , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Imunização , Solanum lycopersicum/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Parasitemia , Coelhos , Análise de Sobrevida
8.
Zoonoses Public Health ; 59(1): 16-22, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21824363

RESUMO

The aim of this study was to isolate yeasts from the faeces of urban bats inhabiting the city of Londrina, Paraná, Brazil and to determine their potential virulence attributes. Seven (12.3%) of 57 bats screened in this study showed yeasts in their faeces. Five species of the genus Candida were isolated: C. guilliermondii, C. krusei, C. lusitaniae, C. parapsilosis, and C. pelliculosa. No phospholipase activity was detected in the egg yolk plate assay; however, all isolates demonstrated protease secretion in skim milk agar. Yeasts isolated from bats produced biofilm on the surface of polystyrene plates and all were classified as intermediate biofilm producers. Minimal inhibitory concentration (MIC) values for fluconazole in the yeasts varied according to the species. Only one isolate (M34 - C. lusitaniae) was considered susceptible dose-dependent to fluconazole. The yeasts were injected intravenously into Swiss mice, and at 15 days post-infection, the animals were killed and portions of their kidneys cultured on Sabouraud dextrose agar medium. All tissues analysed showed positive cultures of Candida spp. This is the first study evaluating the presence of fungi in the faeces of bats in an urban region, where the yeast species found were shown to be potentially pathogenic. As bats are commonly found in cities, these findings indicate the need for continuous surveillance concerning environmental contamination by their excreta.


Assuntos
Antifúngicos/farmacologia , Candida/isolamento & purificação , Candidíase Invasiva/veterinária , Quirópteros/microbiologia , Fezes/microbiologia , Fluconazol/farmacologia , Animais , Biofilmes/crescimento & desenvolvimento , Brasil/epidemiologia , Candida/efeitos dos fármacos , Candida/patogenicidade , Candidíase Invasiva/epidemiologia , Candidíase Invasiva/microbiologia , Cidades , Contagem de Colônia Microbiana , Humanos , Rim/microbiologia , Masculino , Camundongos , Testes de Sensibilidade Microbiana , Modelos Animais , Peptídeo Hidrolases/metabolismo , Fosfolipases/metabolismo , Fatores de Risco , Virulência
9.
Pathog Glob Health ; 106(2): 107-12, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22943546

RESUMO

We report here for the first time the in vitro effects of (1S,2R,4S)-1,7,7-trimethyl-bicyclo[2·2·1]heptan-2-yl-3',4',5'-trimethoxy benzoate (1) and (1S,2R,4S)-1,7,7-trimethyl-bicyclo[2·2·1]heptan-2-yl benzoate (2) on the growth and ultrastructure of Trypanosoma cruzi. These two synthetic compounds exerted an antiproliferative effect on the epimastigote forms of the parasite. The ICs(50/72h) of two synthetic L-bornyl benzoates, 1 and 2, was 10·1 and 12·8 µg/ml, respectively. Both compounds were more selective against epimastigotes than HEp-2 cells. Ultrastructural analysis revealed intense cytoplasmic vacuolization and the appearance of cytoplasmic materials surrounded by membranes. The treatment of peritoneal macrophages with compounds 1 and 2 caused a significant decrease in the number of T. cruzi-infected cells. L-Bornyl benzoate derivatives may serve as a potential source for the development of more effective and safer chemotherapeutic agents against T. cruzi infections.


Assuntos
Antiprotozoários/farmacologia , Benzoatos/farmacologia , Canfanos/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Antiprotozoários/síntese química , Antiprotozoários/toxicidade , Benzoatos/síntese química , Benzoatos/toxicidade , Canfanos/síntese química , Canfanos/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Citoplasma/ultraestrutura , Células Hep G2 , Humanos , Concentração Inibidora 50 , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Trypanosoma cruzi/crescimento & desenvolvimento , Trypanosoma cruzi/ultraestrutura
10.
Life Sci ; 87(11-12): 375-81, 2010 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-20688085

RESUMO

AIMS: the purpose of the present work was to investigate the effect of cyclooxygenase-2 (COX-2) inhibition on the cardiovascular and inflammatory aspects promoted by monosodium glutamate (MSG)-induced obesity in rats. MAIN METHODS: Neonatal Wistar male rats were injected with MSG (4 mg/g body weight ID) or equimolar saline (control). Treatment with celecoxib (50 mg/kg ip) or saline (0.9% NaCl ip) began at 60 days of age. At 90 days, all rats were anesthetized for catheterization of the femoral artery, and the mean arterial pressure (MAP) and heart rate (HR) were recorded once consciousness was regained. KEY FINDINGS: MSG obese rats were hypertensive (MAP=138±4 mm Hg) compared with controls (MAP=118±2 mm Hg). After treatment with celecoxib, the hypertension was attenuated (MAP=126±2 mm Hg) in obese rats without changes in HR. The retroperitoneal and periepididymal fat weighed more in obese rats (Obese: Retro=7.08±0.51, Peri=6.36±0.81, CONTROL: Retro=3.60±0.46; Peri=3.24±0.42), but celecoxib did not alter these parameters. Plasma nitric oxide levels were not different between groups. However, the level of plasma prostaglandins, the immunohistochemical staining of COX-2 in cardiac tissue and plasma lipoperoxidation were higher in obese rats, and celecoxib attenuated these parameters. MSG produced liver steatosis that was also attenuated following celecoxib treatment. SIGNIFICANCE: Our data demonstrate an association between increased blood pressure and products of COX-2 in obese rats, suggesting a role for prostaglandins in the hypertensive and inflammatory aspects of MSG-induced obesity.


Assuntos
Inibidores de Ciclo-Oxigenase 2/uso terapêutico , Hipertensão/tratamento farmacológico , Obesidade/induzido quimicamente , Obesidade/tratamento farmacológico , Glutamato de Sódio/farmacologia , Tecido Adiposo/patologia , Animais , Sangue/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Celecoxib , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase 2/farmacologia , Dinoprostona/sangue , Coração/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Frequência Cardíaca/fisiologia , Hipertensão/etiologia , Hipertensão/fisiopatologia , Inflamação/sangue , Inflamação/tratamento farmacológico , Inflamação/etiologia , Inflamação/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Peróxidos Lipídicos/sangue , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Miocárdio/metabolismo , Nitratos/sangue , Obesidade/complicações , Obesidade/metabolismo , Obesidade/patologia , Obesidade/fisiopatologia , Pirazóis/farmacologia , Pirazóis/uso terapêutico , Ratos , Ratos Wistar , Sulfonamidas/farmacologia , Sulfonamidas/uso terapêutico
11.
Cell Immunol ; 193(1): 90-8, 1999 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-10202116

RESUMO

Suppression of host lymphoproliferative responses to mitogens and Ag is characteristically seen during acute infection with the protozoan parasite Trypanosoma cruzi. We investigated the reciprocal regulation of prostaglandins (PG), TNF-alpha, and nitric oxide (NO) production and their effects on cytokine production and lymphoproliferative responses to parasite Ag and to Con A by spleen cells (SC) from T.-cruzi-infected mice. Large amounts of PGE2, TNF-alpha, and NO were produced during infection. TNF-alpha stimulated PG and NO synthesis, while both mediators inhibited TNF-alpha synthesis. Blocking PG also reduced NO synthesis indicating that PG stimulate NO production. Treatment with indomethacin or NMLA stimulated lymphoproliferation on days 6 and 22 of infection; on day 14, when suppression of proliferation and NO production was maximal, combined inhibition of NO and PG production restored parasite Ag specific and Con A proliferative responses. Blocking PG or NO production increased IL-2, IFN-gamma, and TNF-alpha, but not IL-12 production by SC; IL-10 levels were not reduced. Indomethacin-treated infected mice had higher mortality compared to untreated infected animals. The data indicate that PG, together with NO and TNF-alpha, participate in a complex circuit that controls lymphoproliferative and cytokine responses in T. cruzi infection.


Assuntos
Doença de Chagas/imunologia , Citocinas/biossíntese , Ativação Linfocitária , Prostaglandinas/fisiologia , Doença Aguda , Animais , Indometacina/farmacologia , Interferon gama/biossíntese , Interleucina-2/biossíntese , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico/fisiologia , Fator de Necrose Tumoral alfa/fisiologia , ômega-N-Metilarginina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA